This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $737,899.00 to The University of Texas Health Science Center at San Antonio (UTHSCSA) to conduct research on a nontrauma intervention to treat post-traumatic stress disorder (PTSD) for veterans and service members suffering from a traumatic brain injury (TBI). The award will support this investigative work over a 3-year period from September 1, 2024 to...
The Defense Health Agency awarded a four-year, $936,532 Cooperative Agreement to the University of Texas Health Science Center at San Antonio (UTHSCSA) to implement and evaluate a patient-centered PTSD treatment program for military personnel. This award is funded under the Military Medical Research and Development (CFDA 12.420) program, which supports biomedical research to transform healthcare for service members and the public.
Through this Cooperative Agreement, UTHSCSA will conduct...
The University of Texas Health Science Center at San Antonio (UTHSCSA) received a $508,815 Cooperative Agreement award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to implement and evaluate a patient-centered PTSD treatment program for military personnel. This 4-year award, running from September 1, 2023 to August 31, 2027, will support research to transform healthcare for service members and the public through innovative and...
This $6,964,861 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) funds a longitudinal research study on the future of psychological health care for the military. The primary awardee, The University of Texas Health Science Center at San Antonio, will conduct a multi-year follow-up of over 7,700 participants from previous military mental health clinical trials and studies. The research aims to determine how unique...
The U.S. Defense Health Agency awarded a $2,398,281 Project Grant on September 1, 2024 under the Military Medical Research and Development program (CFDA 12.420) to the Palo Alto Veterans Institute for Research (PAVIR). The grant, titled "Increasing Access to Evidenced-Based PTSD Treatment in the Military: Behavioral Health Technician-Delivered Written Exposure Therapy", aims to determine the effectiveness, acceptability, and fidelity of a Behavioral Health Technician (BHT)-delivered...
This federal Project Grant award for $5,024,305.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports a study to augment cognitive processing therapy (CPT) to prevent suicide risk among patients with post-traumatic stress disorder (PTSD). The primary awardee is The Ohio State University, which will leverage resources and personnel from the Strong Star Consortium at the University of Texas Health Science Center at San...
This $1,312,801 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports the development of an advanced wireless augmented reality-enhanced exposure therapy for post-traumatic stress disorder (PTSD). The prime awardee, Wayne State University, will collaborate with the University of Texas Health Science Center at Houston and the Lowcountry Center for Veterans Research to execute the project.
Key activities...
This $3,141,404 federal Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) aims to evaluate the efficacy of combined cognitive processing therapy and stellate ganglion blocks for treating post-traumatic stress disorder (PTSD). The award, dated September 1, 2024, supports a randomized controlled trial to be conducted by the Rush University Medical Center in Chicago, Illinois over a 4-year performance period ending August...
The University of Texas Health Science Center at San Antonio (UTHSCSA) was awarded a $493,610 Project Grant from the Department of Defense's Military Medical Research and Development (CFDA 12.420) program to conduct a randomized clinical trial utilizing crisis response planning for suicide prevention in military personnel with traumatic brain injury. The grant, awarded on August 1, 2024, will support this research project over a 3-year period, with a final completion date of July 31, 2027. As...
This $2,763,615 federal Project Grant award from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) supports a randomized controlled trial of brief prolonged exposure therapy for injured individuals admitted to a Level I trauma center. The goal is to evaluate the effectiveness of this approach in preventing post-traumatic stress disorder (PTSD) in this patient population. The 4-year study is being conducted by the Baylor Research Institute, a...